Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorOverton, Ian M.
dc.contributor.authorGraham, Shirley
dc.contributor.authorGould, Katherine A.
dc.contributor.authorHinds, Jason
dc.contributor.authorBotting, Catherine H.
dc.contributor.authorShirran, Sally
dc.contributor.authorBarton, Geoffrey J.
dc.contributor.authorCoote, Peter J.
dc.date.accessioned2011-07-05T14:31:05Z
dc.date.available2011-07-05T14:31:05Z
dc.date.issued2011-05-12
dc.identifier.citationOverton , I M , Graham , S , Gould , K A , Hinds , J , Botting , C H , Shirran , S , Barton , G J & Coote , P J 2011 , ' Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus ' , BMC Systems Biology , vol. 5 , 68 . https://doi.org/10.1186/1752-0509-5-68en
dc.identifier.issn1752-0509
dc.identifier.otherPURE: 9195314
dc.identifier.otherPURE UUID: 36458cc0-7536-41a2-a8eb-818ff6ba9d0b
dc.identifier.otherWOS: 000292105100001
dc.identifier.otherScopus: 79955838835
dc.identifier.otherORCID: /0000-0003-3516-3507/work/32169117
dc.identifier.otherORCID: /0000-0001-5190-805X/work/40963235
dc.identifier.urihttps://hdl.handle.net/10023/1911
dc.description.abstractBackground: Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity against Gram-positive bacteria, and particularly S. aureus. Understanding mode of action is a key component of drug discovery and network biology approaches enable a global, integrated view of microbial physiology, including mechanisms of antibiotic killing. We developed a systems-wide functional association network approach to integrate proteome and transcriptome profiles, enabling study of drug resistance and mode of action. Results: The functional association network was constructed by Bayesian logistic regression, providing a framework for identification of antimicrobial peptide (ranalexin) response modules from S. aureus MRSA-252 transcriptome and proteome profiling. These signatures of ranalexin treatment revealed multiple killing mechanisms, including cell wall activity. Cell wall effects were supported by gene disruption and osmotic fragility experiments. Furthermore, twenty-two novel virulence factors were inferred, while the VraRS two-component system and PhoU-mediated persister formation were implicated in MRSA tolerance to cationic antimicrobial peptides. Conclusions: This work demonstrates a powerful integrative approach to study drug resistance and mode of action. Our findings are informative to the development of novel therapeutic strategies against Staphylococcus aureus and particularly MRSA.
dc.format.extent16
dc.language.isoeng
dc.relation.ispartofBMC Systems Biologyen
dc.rights© 2011 Overton et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectRB Pathologyen
dc.subject.lccRBen
dc.titleGlobal network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureusen
dc.typeJournal articleen
dc.contributor.sponsorBBSRCen
dc.contributor.sponsorBBSRCen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Chemistryen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.contributor.institutionUniversity of St Andrews. School of Biologyen
dc.contributor.institutionUniversity of St Andrews. EaSTCHEMen
dc.identifier.doihttps://doi.org/10.1186/1752-0509-5-68
dc.description.statusPeer revieweden
dc.identifier.urlhttp://www.biomedcentral.com/1752-0509/5/68en
dc.identifier.grantnumberBBS/B/14426en
dc.identifier.grantnumberBBS/B/14426en


This item appears in the following Collection(s)

Show simple item record